文献速递神经康复脊髓损伤康复

独立式机器人外骨骼用于脊髓损伤患者物理治疗的可行性研究

Physiotherapy using a free-standing robotic exoskeleton for patients with spinal cord injury: a feasibility study.
PubMed 文献 · J Neuroeng Rehabil · 2021-12-25

本研究评估独立式下肢机器人外骨骼(REX)对脊髓损伤(SCI)患者的可行性与健康相关获益,采用12周干预、12周等待对照及12周随访设计,纳入SCIM-III移动项评分<5者,每周两次治疗。41例筛查中仅3例完成全部24次干预及随访,干预可接受性高,个别患者在功能、疲劳、生活质量、情绪、肌力及瘦体重方面呈积极趋势,但结果异质性大。

要点

  • 独立式外骨骼可使高位损伤患者直立位训练,避免依赖助行器。
  • SCIM-III移动项<5的SCI患者中仅少数符合并完成研究,可行性受限。
  • 干预接受性高,个别患者功能、肌力及瘦体重呈积极趋势。

核心结论

  • 对因SCI导致严重移动障碍的少数患者,独立式外骨骼运动可能存在潜在获益。
  • 需进一步研究确定最可能获益的人群及获益类型与患者特征的关系。

研究设计与样本

  • 12周干预研究,设12周等待对照及12周随访。
  • 纳入SCIM-III移动项评分<5的SCI患者,每周两次在REX(Rex Bionics, Auckland, NZ)独立式下肢机器人外骨骼中治疗。
  • 主要结局为SCIM-III评估的功能,并包含一组次要结局及治疗模式可接受性调查。

主要发现

  • 41例潜在参与者中仅3例(2女1男;ASIA A、C、B各1例)完成全部24次干预及随访评估。
  • 1例在干预阶段功能、疲劳、生活质量及情绪呈积极趋势。
  • 另1例握力、股四头肌肌力及下肢运动功能改善。
  • 2例在干预阶段瘦体重百分比改善。
  • 其余结果因患者、时间点及结局不同而异,干预对所有参与者可接受性高。

关键数值与推荐

  • 纳入标准为SCIM-III移动项评分<5。
  • 干预为每周两次REX独立式下肢机器人外骨骼治疗,共24次。

临床怎么用

  • 对严重移动障碍的SCI患者,可考虑试用独立式外骨骼作为直立位运动训练方式。
  • 治疗前需评估患者是否可能耐受并完成多次干预,因符合条件并完成者比例低。
  • 个体获益差异大,应结合患者特征设定个体化目标并监测功能、肌力及瘦体重等指标。

局限性

  • 41例筛查中仅3例符合并完成研究,样本量极小。
  • 结果异质性大,跨患者、时间点及结局不一致。
  • 可行性结论仅适用于小部分严重移动障碍的SCI患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Evidence is emerging for the use of overground lower limb robotic exoskeletons in the rehabilitation of people with spinal cord injury (SCI), with suggested benefits for gait speed, bladder and bowel function, pain management and spasticity. To date, research has focused on devices that require the user to support themselves with a walking aid. This often precludes use by those with severe trunk, postural or upper limb deficits and places the user in a suboptimal, flexed standing position. Free-standing exoskeletons enable people with higher level injuries to exercise in an upright position. This study aimed to evaluate the feasibility of therapy with a free-standing exoskeleton for those with SCI, and to determine the potential health-related benefits of this intervention. METHODS: This 12-week intervention study with 12-week waitlist control and 12-week follow up, provided people with SCI scoring < 5 on the mobility section of the spinal cord independence measure (SCIM-III) twice weekly therapy in the REX (Rex Bionics, Auckland, NZ), a free-standing lower limb robotic exoskeleton. The primary outcome measure of interest was function, as measured on the SCIM-III. A battery of secondary outcomes was included. Participants also completed a survey on their perceptions of this treatment modality, to determine acceptability. RESULTS: Forty-one potential participants were screened for eligibility. Two females (one ASIA A, one ASIA C) and one male (ASIA B) completed all 24 intervention sessions, and the follow up assessment. One participant showed positive trends in function, fatigue, quality of life and mood during the intervention phase. Grip and quadriceps strength, and lower limb motor function improved in another. Two improved their percentage of lean body mass during the intervention phase. Remaining results were varied across patients, time points and outcomes. The intervention was highly acceptable to all participants. CONCLUSION: With three of 41 potential participants being eligible and completing this study, our results show that there are potential benefits of exercise in a free-standing exoskeleton for people with severe mobility impairment due to SCI, for a small subset of patients. Further research is warranted to determine those most likely to benefit, and the type of benefit depending on the patient characteristics. Trial registration The trial was registered prospectively on 20 April 2018 at www.anzctr.org.au/ (ACTRN12618000626268).

来源:J Neuroeng Rehabil,查看原文。版权归原作者所有。

引用

  1. Postol N, Spratt NJ, Bivard A, et al. Physiotherapy using a free-standing robotic exoskeleton for patients with spinal cord injury: a feasibility study. J Neuroeng Rehabil. 2021. PMID: 34953501. doi:10.1186/s12984-021-00967-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。